<!DOCTYPE html>
<html>
<head>

  
  <meta name="viewport" content="width=device-width, initial-scale=1">
 
 
<style>


.sidebar_circos{
   background-color: #EFFFFF;
}


.container{
   width=100%;
   position: relative;
   min-height: 100vh;
}


.flex-container{
   margin-bottom: -100px;
}


.flex-container .flex-right img{
  width: 96%;
	vertical-align: top;
}






</style>


</head>



<body>
   
   <div class= ".container"> 
   
    <div class="flex-container" style="display: flex;">
        <div style="width: 50%; padding: 50px; ">
                <h1 style = "font-size:37px; font-family: Verdana; text-align: center;">Welcome to the MPNST Surveyor</h1> 
  
                     <br>
                     <hr style="height:3px; visibility:hidden;" />
    
    <p style = "font-family: 'Verdana'; font-size:17px; text-align: center; color:black; LINE-HEIGHT:34px">The MPNST Surveyor is a central database for analyzing and displaying genomic data gathered from the sequencing of 96 malignant peripheral nerve sheath tumors. The "SAMPLES" tab provides summarized clinical and genomic data for each tumor sample. The "EXPLORE" tab contains interactive circos genome plots, and corresponding SNV, INDEL, and CN data. The "MUTATION" tab allows the user to query SNVS or INDELS for multiple samples and view the sequencing image for each mutation. Finally, the "cBioPortal" tab contains a link to the GeM Consortium private instance of cBioPortal.</p>
                      <br>
                      <br>                    
   
   <p style = "font-family: 'Verdana'; font-size:17px; text-align: center; color:black; LINE-HEIGHT:34px">The MPNST Surveyor is the result of a collaboration between the Park Lab at HMS and the the Genomics of MPNST (GeM) Consortium. The GeM Consortium, made possible by an anonymous philanthropic gift to the Multidisciplinary Neurofibromatosis Program at Boston Children's Hospital, is a multi-institutional descriptive study of clinical, pathological, and molecular features of malignant peripheral nerve sheath tumors (MPNSTs), a rare soft-tissue sarcoma that is the most common malignancy affecting persons with Neurofibromatosis Type 1 (NF1).</p>
                      <br>
                      <br> 
                     
   <p style = "font-family: 'Verdana'; font-size:17px; text-align: center; color:black; LINE-HEIGHT:34px">
      Other NF1-related tumors such as plexiform neurofibromas (PN) and atypical neurofibromas (AN) are precursors of MPNSTs, and will also be studied in some cases. Paired normal non-tumor specimens (i.e., peripheral blood) will also be studied for comparison. The GeM Consortium has employed a variety of molecular analysis techniques to improve the biological understanding of NF1-related tumors. 
   </p>
      
                     <br>
                     <br>
      
    <p style = "font-family: 'Verdana'; font-size:17px; text-align: center; color:black; LINE-HEIGHT:34px">
      Thank you for visiting the MPNST Surveyor. To learn more about the GeM Consortium, please visit the <a href="https://www.nfresearch-childrens.org/">NF Research Initiative Website</a>. There will be updated information on the progress being made, and you can find out more about the GeM Consortium and the NF Research Initiative.
   </p>
                     
        </div>
        
        
        
           <div class="flex-right" style="flex: 1 1 0; padding: 40px; text-align: center;">
             
                  <br>
                     
                 <img class="img-responsive" src="logos_current.png" height="720" width="1155">
                   
                   <br>
                   <br>
               

           </div>
        
   </div>

  </div> 
   
</body>
</html> 
